Enhancing treatment options of triple-negative breast cancer
New research trials the use of image-guided co-drug delivery to target difficult tumour types. Approximately 15-20% of breast cancer cases are described as triple-negative, meaning they do not have receptors for the hormones estrogen or progesterone, and do not...
Dr Cecilia Mattevi Awarded The ACS Nano Champion
LCN academic Dr Cecilia Mattevi and her collaborators have been awarded the ACS Nano Champion award for their paper ‘Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic’. The paper can be read here.
Using nanomaterials and biosensors to diagnose
LCN Professor Molly Stevens and her research group were interviewed for the Winter edition of Imperial Magazine. The article explores the group’s research into the fast and accurate diagnosis of diseases like HIV and Malaria. To read the full article please...